Semaglutide for treating obesity-related heart failure with preserved ejection fraction [TSID11788]Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 [TSID11827]Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC